Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT03209154

An Interventional Multidisciplinary Approach to Individualize Blood Pressure Treatment

The aim of the study is to investigate and explore the most important aspects of drug-adherence in the treatment of hypertension in order to improve treatment and blood pressure control, implying that new knowledge will reduce morbidity and mortality.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Uncontrolled Hypertension

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Oslo University Hospital

Oslo, 0424, Norway

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Signed informed consent
  • Uncontrolled hypertension
  • A stable medication regimen for at least 4 weeks of ≥ 2 antihypertensive agents
  • No planned changes in antihypertensive drugs

Exclusion criteria

  • Withdrawal of consent
  • 24-h systolic ambulatory blood pressure >/= 170 mmHg
  • Patients with inadequate Norwegian language skills
  • Positive pregnancy test
  • Known alcohol or drug abuse
  • estimated glomerular filtration rate <30 mL/min/1.73m2
  • Albumin/creatinin ratio >300 mg/mmol
  • Any reason why, in the opinion of the investigator, the patient should not participate

Treatment and study plan

Therapeutic drug monitoring

Diagnostic Test

Therapeutic drug monitoring will be performed.

Home blood pressure monitoring

Device

Patients will perform home blood pressure monitoring at home.

Primary outcomes

  1. Blood pressure control

    Time frame: 3 months after baseline

    Change in systolic daytime ambulatory blood pressure.

Sponsors and collaborators

Lead sponsor

Oslo University Hospital

Other

Collaborators

  • Haukeland University Hospital
  • St. Olavs Hospital
  • University Hospital of North Norway
  • University of Oslo

Registry information

Official study title

Individualized Blood Pressure Treatment: a Multidisciplinary Approach to Uncontrolled Hypertension in Order to Reduce Morbidity and Mortality

Acronym: IDA

Important dates

Study start
2017
Primary completion
2022
Study completion
2025
First posted
Jul 6, 2017
Registry last updated
Mar 25, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.